Suchergebnisse - "Breast neoplasms/mortality"
-
1
Autoren: et al.
Quelle: Annals of oncology, vol. 36, no. 4, pp. 460-468
Schlagwörter: Male, Adult, Breast Neoplasms, cancer mortality, predictions, breast cancer, European Union, UK, Middle Aged, Europe, Humans, Female, Breast Neoplasms/mortality, Breast Neoplasms/epidemiology, Europe/epidemiology, Aged, European Union/statistics & numerical data, Mortality/trends, Neoplasms/mortality, Neoplasms/epidemiology, Neoplasms, Mortality
Dateibeschreibung: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40074664
https://hdl.handle.net/2434/1153545
https://doi.org/10.1016/j.annonc.2025.01.014
https://serval.unil.ch/notice/serval:BIB_5D6E051C54CE
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_5D6E051C54CE6
https://serval.unil.ch/resource/serval:BIB_5D6E051C54CE.P001/REF.pdf
https://www.sciencedirect.com/science/article/pii/S0923753425000225
https://doi.org/10.1016/j.annonc.2025.01.014
https://hdl.handle.net/11585/1008875 -
2
Autoren: et al.
Quelle: Lousdal, M L, Lash, T L, Flanders, W D, Brookhart, M A, Kristiansen, I S, Vedsted, P & Støvring, H 2025, 'A Quasi-experimental Study of General Practices' Referral to Mammography in the Posttrial Treatment Era', Epidemiology, vol. 36, no. 3, pp. 401-407. https://doi.org/10.1097/EDE.0000000000001841
Schlagwörter: Epidemiologic, Denmark, General Practice, Breast Neoplasms, Middle Aged, Confounding Factors, Cohort Studies, Risk Factors, Epidemiology/methods, Humans, Female, Breast neoplasms/mortality, Breast neoplasms/prevention and control, Referral and Consultation, Early Detection of Cancer, Mammography, Aged
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39855264
-
3
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Br J Cancer
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Dipòsit Digital de la UB
instname
RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
Universidad Pontificia de Salamanca
Castro-Espin, C, Cairat, M, Navionis, A-S, Dahm, C C, Antoniussen, C S, Tjønneland, A, Mellemkjær, L, Mancini, F R, Hajji-Louati, M, Severi, G, Le Cornet, C, Kaaks, R, Schulze, M B, Masala, G, Agnoli, C, Sacerdote, C, Crous-Bou, M, Sánchez, M-J, Amiano, P, Chirlaque, M-D, Guevara, M, Smith-Byrne, K, Heath, A K, Christakoudi, S, Gunter, M J, Rinaldi, S, Agudo, A & Dossus, L 2024, ' Prognostic role of pre-diagnostic circulating inflammatory biomarkers in breast cancer survival : evidence from the EPIC cohort study ', British Journal of Cancer, vol. 131, no. 9, pp. 1496-1505 . https://doi.org/10.1038/s41416-024-02858-6
Castro-Espin, C, Cairat, M, Navionis, A-S, Dahm, C C, Antoniussen, C S, Tjønneland, A, Mellemkjær, L, Mancini, F R, Hajji-Louati, M, Severi, G, Le Cornet, C, Kaaks, R, Schulze, M B, Masala, G, Agnoli, C, Sacerdote, C, Crous-Bou, M, Sánchez, M-J, Amiano, P, Chirlaque, M-D, Guevara, M, Smith-Byrne, K, Heath, A K, Christakoudi, S, Gunter, M J, Rinaldi, S, Agudo, A & Dossus, L 2024, 'Prognostic role of pre-diagnostic circulating inflammatory biomarkers in breast cancer survival : evidence from the EPIC cohort study', British Journal of Cancer, vol. 131, no. 9, pp. 1496-1505. https://doi.org/10.1038/s41416-024-02858-6Schlagwörter: Inflammation/blood, Tumor Necrosis Factor-alpha/blood, Adult, Pronòstic mèdic, Postmenopause/blood, Breast Neoplasms/mortality, Breast Neoplasms, Article, Interleucina-6, Càncer de mama, Cohort Studies, Breast cancer, Diagnosis, Methods, Biomarkers, Tumor, Humans, Mortality, Life Style, Aged, Proportional Hazards Models, Inflammation, Interleukin-10/blood, Inflamación, Interleukin-6, Tumor Necrosis Factor-alpha, Biochemical markers, Inflammation/blood [MeSH], Female [MeSH], 631/67/2324, Aged [MeSH], Adult [MeSH], Humans [MeSH], 692/53/2422, Breast Neoplasms/blood [MeSH], Postmenopause/blood [MeSH], Middle Aged [MeSH], Tumor Necrosis Factor-alpha/blood [MeSH], 692/4028/67/1347, Inflammation/mortality [MeSH], Cohort Studies [MeSH], Proportional Hazards Models [MeSH], Interleukin-10/blood [MeSH], Biomarkers, Tumor/blood [MeSH], Prognosis [MeSH], Interleukin-6/blood [MeSH], Breast Neoplasms/diagnosis [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], article, Neoplasias de la Mama, Middle Aged, Prognosis, Interleukin-10, Postmenopause, Biomarkers, Tumor/blood, Marcadors bioquímics, Tumor/blood, Cohort studies, Female, Interleukin-6/blood, Breast neoplasms, Modelos de Riesgos Proporcionales, Biomarkers
Dateibeschreibung: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39342063
https://hdl.handle.net/2445/216581
https://hdl.handle.net/10668/24322
https://ora.ox.ac.uk/objects/uuid:1540e051-e2ef-4b8c-854f-b2bb702965cc
https://doi.org/10.1038/s41416-024-02858-6
https://curis.ku.dk/ws/files/411757493/s41416_024_02858_6.pdf
https://repository.publisso.de/resource/frl:6496580
http://www.scopus.com/inward/record.url?scp=85205221178&partnerID=8YFLogxK
https://pure.au.dk/portal/en/publications/702b1955-fff8-43a5-9fd1-59978afe26ae
https://doi.org/10.1038/s41416-024-02858-6 -
4
Autoren: et al.
Quelle: Breast Cancer
Schlagwörter: Clinical Trials as Topic, United States Food and Drug Administration, Breast Neoplasms, Antineoplastic Agents, United States, Progression-Free Survival, ddc, Original Article, Breast cancer, Early breast cancer, Cancer drugs, Clinical trials, Antibody-drug conjugates, FDA approval, Value-based pricing, Innovation, Biomarker, Antibody, HER2, Hormone receptor, BRCA, Quality of life, Overall survival, Progression-free survival, Tumor response, Objective response rate, ESMO-MCBS, Metastatic breast cancer, Quality of Life, Humans, United States [MeSH], Progression-Free Survival [MeSH], Antineoplastic Agents/economics [MeSH], United States Food and Drug Administration [MeSH], Quality of Life [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Female [MeSH], Humans [MeSH], Breast Neoplasms/drug therapy [MeSH], Drug Approval [MeSH], Clinical Trials as Topic [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Female, Drug Approval
Dateibeschreibung: application/pdf
-
5
Autoren: et al.
Quelle: Breast Cancer Res Treat
Schlagwörter: Adult, 0301 basic medicine, Receptor, ErbB-2, Research, Breast Neoplasms, Middle Aged, Breast cancer, Prognostic biomarker, Predictive biomarker, EndoPredict, Adjuvant chemotherapy, Risk stratification, Prognosis, Risk Assessment, Disease-Free Survival, ddc, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Receptors, Estrogen, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Female, Prospective Studies, Aged [MeSH], Receptor, ErbB-2/metabolism [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Neoplasm Staging [MeSH], Risk Assessment/methods [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Female [MeSH], Receptors, Estrogen/metabolism [MeSH], Adult [MeSH], Receptors, Progesterone/metabolism [MeSH], Humans [MeSH], Prospective Studies [MeSH], Treatment Outcome [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Biomarkers, Tumor/metabolism [MeSH], Disease-Free Survival [MeSH], Prognosis [MeSH], Neoplasm Recurrence, Local, Receptors, Progesterone, Aged, Neoplasm Staging
Dateibeschreibung: application/pdf
-
6
Autoren: et al.
Quelle: de Boniface, J, Filtenborg Tvedskov, T, Rydén, L, Szulkin, R, Reimer, T, Kühn, T, Kontos, M, Gentilini, O D, Olofsson Bagge, R, Sund, M, Lundstedt, D, Appelgren, M, Ahlgren, J, Norenstedt, S, Celebioglu, F, Sackey, H, Scheel Andersen, I, Hoyer, U, Nyman, P F, Vikhe Patil, E, Wieslander, E, Dahl Nissen, H, Alkner, S, Andersson, Y, Offersen, B V, Bergkvist, L, Frisell, J, Christiansen, P & SENOMAC Trialists’ Group 2024, 'Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases', The New England Journal of Medicine, vol. 390, no. 13, pp. 1163-1175. https://doi.org/10.1056/NEJMoa2313487
for the SENOMAC Trialists’ Group* 2024, 'Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases', New England Journal of Medicine, vol. 390, no. 13, pp. 1163-1175. https://doi.org/10.1056/NEJMoa2313487Schlagwörter: Sentinel Lymph Node Biopsy, Lymph Node Excision/methods, Lymphadenopathy, Breast Neoplasms/mortality, Breast Neoplasms, Combined Modality Therapy, Disease-Free Survival, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Axilla, Lymph Nodes/pathology, Lymphadenopathy/pathology, Humans, Lymph Node Excision, Sentinel Lymph Node/pathology, Female, Lymph Nodes, Sentinel Lymph Node, Follow-Up Studies
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38598571
https://vbn.aau.dk/da/publications/345a4760-f47c-4212-8540-538c146867c1
http://www.scopus.com/inward/record.url?scp=85190242475&partnerID=8YFLogxK
https://doi.org/10.1056/NEJMoa2313487
https://portal.findresearcher.sdu.dk/da/publications/b987cbcf-ceae-4918-aaa9-3b91213c7acd
https://doi.org/10.1056/NEJMoa2313487
http://www.scopus.com/inward/record.url?scp=85190242475&partnerID=8YFLogxK
https://doi.org/10.1056/NEJMoa2313487
https://pure.au.dk/portal/en/publications/a02a3737-e344-4184-aabe-8a9e24d13f3e -
7
Autoren: et al.
Quelle: Front Immunol
Frontiers in Immunology, Vol 16 (2025)
Stagaard, R, Jensen, A, Schauer, T, Bay, M L, Tavanez, A R, Wielsøe, S, Peletier, M, Strøbech, J E, Oria, V O, Zornhagen, K W, Albrechtsen, R, Christensen, J F & Erler, J T 2025, ' Exercise boost after surgery improves survival in model of metastatic breast cancer ', Frontiers in Immunology, vol. 16, 1533798 . https://doi.org/10.3389/fimmu.2025.1533798Schlagwörter: Mice, Inbred BALB C, Triple Negative Breast Neoplasms/mortality, Immunology, Triple Negative Breast Neoplasms, RC581-607, surgery, Mice, Disease Models, Animal, breast cancer, physical exercise, Physical Conditioning, Animal, Cell Line, Tumor, metastasis, tumor microenvironment, Animals, Humans, Female, Immunologic diseases. Allergy, Neoplasm Metastasis
Dateibeschreibung: application/pdf
-
8
Autoren: et al.
Quelle: Breast Cancer, 31, 2, pp. 263-271
Schlagwörter: Artificial intelligence, Receptor, ErbB-2, Natural language processing, Pathology - Radboud University Medical Center, Breast Neoplasms, Bone Neoplasms, Breast neoplasms pathology, 3. Good health, Artificial Intelligence, Information retrieval, Humans, Female, Breast neoplasms metastasis, Autopsy, Breast neoplasms mortality
-
9
Autoren: et al.
Quelle: Clin Exp Metastasis
Schlagwörter: Adult, Aged, 80 and over, Research Paper, Breast cancer, Metastasis, Oligometastasic disease, Stereotactic radiotherapy, Brain metastases, Brain Neoplasms, Breast Neoplasms, Middle Aged, Radiosurgery, ddc, Female [MeSH], Brain Neoplasms/radiotherapy [MeSH], Aged, 80 and over [MeSH], Brain Neoplasms/secondary [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Brain Neoplasms/surgery [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Breast Neoplasms/radiotherapy [MeSH], Radiosurgery/methods [MeSH], Neoplasm Recurrence, Local/radiotherapy [MeSH], Breast Neoplasms/surgery [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], 03 medical and health sciences, 0302 clinical medicine, Humans, Female, Neoplasm Recurrence, Local, Neoplasm Metastasis, Retrospective Studies, Aged
Dateibeschreibung: application/pdf; pdf
-
10
Autoren: et al.
Weitere Verfasser: et al.
Quelle: J Pathol Clin Res
The Journal of Pathology: Clinical Research, Vol 10, Iss 6, Pp n/a-n/a (2024)Schlagwörter: Adult, Breast Neoplasms/pathology, Mitosis, Breast Neoplasms, SDG 3 – Goede gezondheid en welzijn, Computer-Assisted, Deep Learning, SDG 3 - Good Health and Well-being, Predictive Value of Tests, Artificial Intelligence, Breast Neoplasms Pathology, Image Interpretation, Computer-Assisted, Journal Article, Pathology, Mitotic Index, RB1-214, Humans, Image Interpretation, Aged, mitosis, Breast Neoplasms Mortality, deep learning, Reproducibility of Results, Middle Aged, artificial intelligence, Prognosis, machine learning, histopathology, outcome, Original Article, Female, prognosis
Dateibeschreibung: application/pdf
-
11
Autoren: et al.
Quelle: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-16 (2024)Schlagwörter: Male, Adult, Proximal femoral metastasis, Bone Neoplasms, Breast Neoplasms, Osteolysis, Kaplan-Meier Estimate, Humans, Femur, RC254-282, Aged, Retrospective Studies, Aged, 80 and over, Osteolytic bone lesions, Aged, 80 and over [MeSH], Femoral Neoplasms/radiotherapy [MeSH], Radiotherapy, Adjuvant/methods [MeSH], Aged [MeSH], Prostatic Neoplasms/mortality [MeSH], Radiotherapy, Adjuvant/adverse effects [MeSH], Prostatic Neoplasms/pathology [MeSH], Femoral Neoplasms/secondary [MeSH], Breast Neoplasms/radiotherapy [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Osteolysis/etiology [MeSH], Multimodal cancer therapies, Fractures, Spontaneous/surgery [MeSH], Palliative Care/methods [MeSH], Bone Neoplasms/surgery [MeSH], Male [MeSH], Breast Neoplasms/surgery [MeSH], Prostatic Neoplasms/surgery [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Bone Neoplasms/radiotherapy [MeSH], Female [MeSH], Adult [MeSH], Intramedullary nailing, Kaplan-Meier Estimate [MeSH], Humans [MeSH], Fractures, Spontaneous/etiology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Impending fracture, Skeletal-related events, Femur/surgery [MeSH], Femur/pathology [MeSH], Bone Neoplasms/secondary [MeSH], Femoral Neoplasms/mortality [MeSH], Bone Neoplasms/mortality [MeSH], Pathological fracture, Femur/radiation effects [MeSH], Research, Femoral Neoplasms/surgery [MeSH], Femoral Neoplasms, Palliative Care, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Middle Aged, Fractures, Spontaneous, Female, Radiotherapy, Adjuvant
-
12
Autoren: et al.
Quelle: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)Schlagwörter: Adult, Physical activity, Receptor, ErbB-2, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Breast Neoplasms, Middle Aged, Metastatic breast cancer, Prognosis, Progression-Free Survival, ddc, Molecular subtype, Surveys and Questionnaires [MeSH], Female [MeSH], Aged [MeSH], Adult [MeSH], Receptor, ErbB-2/metabolism [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Prospective Studies [MeSH], Progression-Free Survival [MeSH], Middle Aged [MeSH], Diet and physical activity during and after cancer treatment, IPAQ, Prognosis [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Registries [MeSH], Exercise [MeSH], Surveys and Questionnaires, Humans, Female, Prospective Studies, Registries, Neoplasm Metastasis, Exercise, RC254-282, Aged
Dateibeschreibung: application/pdf; pdf
-
13
Autoren: et al.
Quelle: Breast Cancer Res
Breast Cancer Research, Vol 26, Iss 1, Pp 1-10 (2024)Schlagwörter: Endocrine therapy, Adult, Receptor, ErbB-2, Pyridines, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Breast Neoplasms, Palbociclib, Middle Aged, Antibody–drug conjugates, Aged [MeSH], HER2-low, Receptor, ErbB-2/metabolism [MeSH], Breast cancer, Receptor, ErbB-2/genetics [MeSH], Neoplasm Staging [MeSH], Piperazines/therapeutic use [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Female [MeSH], Pyridines/therapeutic use [MeSH], Receptors, Estrogen/metabolism [MeSH], Adult [MeSH], Humans [MeSH], Breast Neoplasms/genetics [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Biomarkers, Tumor/metabolism [MeSH], Prognosis [MeSH], Prognosis, Piperazines, Receptors, Estrogen, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Female, RC254-282, Aged, Neoplasm Staging
-
14
Autoren: et al.
Quelle: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)Schlagwörter: Adult, Rural Population, Survival, Receptor, ErbB-2, Breast Neoplasms, Ethiopia, Aged [MeSH], Intrinsic subtypes, Receptor, ErbB-2/metabolism [MeSH], Ethiopia/epidemiology [MeSH], Breast Neoplasms/therapy [MeSH], PAM50, Africa, Chemotherapy, Adjuvant/methods [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Female [MeSH], Receptors, Estrogen/metabolism [MeSH], Adult [MeSH], Receptors, Progesterone/metabolism [MeSH], Humans [MeSH], Prospective Studies [MeSH], Breast Neoplasms/genetics [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Breast Cancer, Rural Population [MeSH], Immunohistochemistry [MeSH], Biomarkers, Tumor/metabolism [MeSH], Research, Prognosis [MeSH], Gene Expression Profiling [MeSH], Biomarkers, Tumor, Humans, Prospective Studies, RC254-282, Aged, ddc:610, Gene Expression Profiling, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Prognosis, Immunohistochemistry, Receptors, Estrogen, Chemotherapy, Adjuvant, Female, Receptors, Progesterone
Dateibeschreibung: application/pdf
-
15
Autoren: et al.
Quelle: Front Immunol
Frontiers in Immunology, Vol 15 (2024)
Frontiers in immunology, vol. 15, pp. 1396777Schlagwörter: 0301 basic medicine, Immunology, Breast Neoplasms, 616.07, cancer immunology, Mice, 03 medical and health sciences, Breast cancer, breast cancer, Gasdermins, Cell Line, Tumor, Tumor Microenvironment, Animals, Humans, Cancer immunology, Mice, Knockout, 0303 health sciences, gasdermin D, Liver Neoplasms, Intracellular Signaling Peptides and Proteins, RC581-607, Phosphate-Binding Proteins, Gasdermin D, Toll-like receptor 7, 3. Good health, Disease Models, Animal, Cytokines, Female, Immunotherapy, immunotherapy, Immunologic diseases. Allergy, Phosphate-Binding Proteins/metabolism, Phosphate-Binding Proteins/genetics, Breast Neoplasms/immunology, Breast Neoplasms/mortality, Breast Neoplasms/genetics, Intracellular Signaling Peptides and Proteins/genetics, Intracellular Signaling Peptides and Proteins/metabolism, Tumor Microenvironment/immunology, Cytokines/metabolism, Liver Neoplasms/immunology, Liver Neoplasms/mortality, Liver Neoplasms/genetics
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39224600
https://doaj.org/article/f4b80242743a430885ba5c660f5b5289
https://serval.unil.ch/notice/serval:BIB_FA09590DDCEE
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_FA09590DDCEE3
https://serval.unil.ch/resource/serval:BIB_FA09590DDCEE.P001/REF.pdf -
16
Autoren: et al.
Quelle: Breast J
The Breast Journal, Vol 2024 (2024)Schlagwörter: Breast Neoplasms / drug therapy, Receptor, ErbB-2, receptor, receptors, Receptor, ErbB-2 / metabolism, chemotherapy, Class I Phosphatidylinositol 3-Kinases / genetics, ErbB-2, 0302 clinical medicine, breast neoplasms, estrogen, antineoplastic agents, RC254-282, Breast Neoplasms / mortality, breast tumor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Receptors, Estrogen / metabolism, Breast Neoplasms / therapy, Receptors, Progesterone / metabolism, Receptors, Estrogen, Chemotherapy, Adjuvant, Antineoplastic Agents, Hormonal / therapeutic use, Breast Neoplasms / pathology, Female, PIK3CA mutations, Public aspects of medicine, RA1-1270, Receptors, Progesterone, Research Article, Adult, tumor, disease-free survival, Antineoplastic Agents, Hormonal, Class I Phosphatidylinositol 3-Kinases, Croatia, Neoplasm Recurrence, Local / genetics, Breast Neoplasms, progesterone, Disease-Free Survival, 03 medical and health sciences, adjuvant, local, Biomarkers, Tumor, Humans, Retrospective Studies, Aged, Receptor, ErbB-2 / genetics, biomarkers, neoplasm recurrence, hormonal, Biomarkers, Tumor / genetics, Breast Neoplasms / genetics, Mutation, mutation, Neoplasm Recurrence, Local
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39742376
https://doaj.org/article/58fd4feb40884d6bb8fd7ad6d6f40a50
https://onlinelibrary.wiley.com/doi/10.1155/2024/5648845
https://doi.org/10.1155/2024/5648845
https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.16_suppl.e12512
https://doi.org/10.1200/JCO.2024.42.16_suppl.e12512
https://urn.nsk.hr/urn:nbn:hr:105:788167
https://doi.org/10.1155/2024/5648845 -
17
Autoren: et al.
Quelle: Breast Cancer Res
Breast Cancer Research, Vol 26, Iss 1, Pp 1-11 (2024)Schlagwörter: Adult, Neoplasm, Residual, Receptor, ErbB-2, Biopsy, Breast Neoplasms, Disease-Free Survival, Breast cancer, Lymphocytes, Tumor-Infiltrating, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, TILs, RC254-282, Aged, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Serial biopsies, Middle Aged, Prognosis, Neoadjuvant Therapy, Ki-67 Antigen, Treatment Outcome, Receptors, Estrogen, Chemotherapy, Adjuvant, Neoadjuvant therapy, Aged [MeSH], Receptor, ErbB-2/metabolism [MeSH], Neoadjuvant Therapy/methods [MeSH], Ki-67 Antigen/metabolism [MeSH], Chemotherapy, Adjuvant/methods [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Female [MeSH], Receptors, Estrogen/metabolism [MeSH], Adult [MeSH], Biopsy [MeSH], Receptors, Progesterone/metabolism [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Breast Neoplasms/drug therapy [MeSH], Breast Neoplasms/metabolism [MeSH], Middle Aged [MeSH], Lymphocytes, Tumor-Infiltrating/metabolism [MeSH], Neoplasm, Residual/pathology [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Lymphocytes, Tumor-Infiltrating/immunology [MeSH], Biomarkers, Tumor/metabolism [MeSH], Disease-Free Survival [MeSH], Prognosis [MeSH], Ki-67, Female, Receptors, Progesterone
-
18
Autoren: et al.
Quelle: ISSN: 0893-3952 ; Modern pathology, vol. 37, no. 10 (2024) 100570.
Schlagwörter: info:eu-repo/classification/ddc/616.07, CDH1 mutations, E-cadherin immunohistochemistry, Invasive lobular carcinoma, Prognosis, Humans, Cadherins / genetics, Cadherins / analysis, Carcinoma, Lobular / genetics, Lobular / pathology, Lobular / metabolism, Breast Neoplasms / genetics, Breast Neoplasms / pathology, Breast Neoplasms / mortality, Female, Middle Aged, Mutation, Antigens, CD / genetics, Aged, Retrospective Studies, Biomarkers, Tumor / genetics, Tumor / analysis, Adult, 80 and over, Immunohistochemistry
Relation: info:eu-repo/semantics/altIdentifier/pmid/39025406; unige:182881
Verfügbarkeit: https://archive-ouverte.unige.ch/unige:182881
-
19
Autoren: et al.
Quelle: Nouhravesh, N, Strange, J E, Sindet-Pedersen, C, Holt, A, Tønnesen, J, Andersen, C F, Nielsen, S K, Grove, E L, Nielsen, D, Schou, M & Lamberts, M 2024, 'Impact of breast-, gastrointestinal-, and lung cancer on prognosis in patients with first-time pulmonary embolism : A Danish nationwide cohort study', International Journal of Cardiology, vol. 406, 132001. https://doi.org/10.1016/j.ijcard.2024.132001
Schlagwörter: Breast cancer, Cardio-oncology, Gastrointestinal cancer, Lung cancer, Pulmonary embolism, Prognosis, Follow-Up Studies, Humans, Middle Aged, Risk Factors, Male, Breast Neoplasms/mortality, Denmark/epidemiology, Pulmonary Embolism/mortality, Aged, 80 and over, Female, Lung Neoplasms/mortality, Registries, Gastrointestinal Neoplasms/epidemiology, Cohort Studies
-
20
Autoren: et al.
Quelle: Front Public Health
Frontiers in Public Health, Vol 11 (2023)
Frontiers in public health, vol. 11, pp. 1129708Schlagwörter: Employment, Return to work, Breast Neoplasms, Statistics, Nonparametric, Breast cancer, breast cancer, cancer registry, Humans, Registries, Occupations, Proportional Hazards Models, Cohort, cohort, return to work, Cancer registry, Occupational exposure, occupational epidemiology, 3. Good health, Female, Breast Neoplasms/diagnosis, Breast Neoplasms/epidemiology, Breast Neoplasms/mortality, Breast Neoplasms/pathology, Occupations/statistics & numerical data, Switzerland/epidemiology, Registries/statistics & numerical data, Employment/statistics & numerical data, female worker, occupational exposure, Occupational epidemiology, Female worker, Public Health, Public aspects of medicine, RA1-1270, Switzerland
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37089493
https://doaj.org/article/e2800548480d4927a79eb96c44f600aa
https://serval.unil.ch/notice/serval:BIB_20985BCC93B9
https://serval.unil.ch/resource/serval:BIB_20985BCC93B9.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_20985BCC93B98
Nájsť tento článok vo Web of Science 
Full Text Finder 
Full Text